Posts

Posted on

INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Triterras, Inc.

NEW YORK, Dec. 18, 2020 (GLOBE NEWSWIRE) — The law firm of Kirby McInerney LLP is investigating potential claims against Triterras, Inc. (“Triterras” or the “Company”) (NASDAQ: TRIT). The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

On December 17, 2020, Triterras stated that Rhodium Resources Pte. Ltd. (“Rhodium”) was seeking a moratorium to shield itself from creditor actions while it planned a restructuring of its debts and continue its business as a going concern. The Company stated that “Rhodium was instrumental to the initial launch of the Company’s Kratos platform and the platform’s attractiveness to the commodities trading and trade financings communities” and that “substantially all of the users of the Kratos platform during the year ended February 29, 2020 were referred to the platform by Rhodium and its subsidiaries who accounted for 26.5% of the Company’s revenues.”

On this news, the price of Triterras shares fell by $4.11 per share, or approximately 31%, to close at $9.09 per share on December 17, 2020.

If you purchased or otherwise acquired Triterras securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney LLP at 212-371-6600, by email at [email protected], or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.


Kirby McInerney LLP
 is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website: http://www.kmllp.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts
Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-371-6600
https://www.kmllp.com
[email protected]



Posted on

Morgan Stanley Announces Anticipated Resumption of Its Common Stock Repurchase Plan

Morgan Stanley Announces Anticipated Resumption of Its Common Stock Repurchase Plan

NEW YORK–(BUSINESS WIRE)–
On December 18, 2020, the Board of Governors of the Federal Reserve System (FRB) notified Morgan Stanley (NYSE: MS) that it would be permitted to resume repurchases of common stock in the first quarter of 2021, consistent with the FRB’s recently announced distribution limitations. The Firm’s Board of Directors authorized the repurchases of outstanding common stock of up to $10 billion in 2021 in recognition of our significant capital buffer.

James P. Gorman, Chairman and Chief Executive Officer of Morgan Stanley, said, “The results announced today allow us to restart our share repurchase program in January, and we expect to continue the program throughout the coming year. With over 400bps of excess capital, we are in a position to continue to invest in our businesses while returning capital to shareholders and absorbing market volatility.”

The repurchases will be subject to market conditions and the Firm’s financial performance. Repurchases under the program in any period will be consistent with the Firm’s Stress Capital Buffer (SCB) requirement and other regulatory capital standards.

Morgan Stanley is a leading global financial services firm providing investment banking, securities, wealth management and investment management services. With offices in more than 41 countries, the Firm’s employees serve clients worldwide including corporations, governments, institutions and individuals. For more information about Morgan Stanley, please visit www.morganstanley.com.

Media Relations: Wesely McDade, 212.761.2430

Investor Relations: Sharon Yeshaya, 212.761.1632

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo
Posted on

Fairholme Funds, Inc. December 2020 Dividend Distributions

Fairholme Funds, Inc. December 2020 Dividend Distributions

The Fairholme Fund (NASDAQ: FAIRX) will not be paying a dividend in 2020.

MIAMI–(BUSINESS WIRE)–Fairholme Funds, Inc.:

THE FAIRHOLME FOCUSED INCOME FUND (FOCIX)

On December 18, 2020, the Fairholme Focused Income Fund (NASDAQ: FOCIX) distributed an Ordinary Income dividend of $0.01656 per share to shareholders of record as of December 17, 2020. The Fairholme Focused Income Fund’s Net Asset Value (“NAV”) was reduced by the total amount of the distribution.

The Record Date, Ex-Dividend Date, Payable Date, and Cents-Per-Share are as follows:

   Distribution Type

 

Record Date

 

   Ex-Dividend Date

 

   Payable Date

 

 Cents-Per-Share

Ordinary Income

 

   December 17, 2020

 

   December 18, 2020

 

   December 18, 2020

 

$0.01656

Total

 

 

 

 

 

 

 

$0.01656

THE FAIRHOLME ALLOCATION FUND (FAAFX)

On December 18, 2020, the Fairholme Allocation Fund (NASDAQ: FAAFX) distributed an Ordinary Income dividend of $0.02063 per share to shareholders of record as of December 17, 2020. The Fairholme Allocation Fund’s Net Asset Value (“NAV”) was reduced by the total amount of the distribution.

The Record Date, Ex-Dividend Date, Payable Date, and Cents-Per-Share are as follows:

  Distribution Type

 

Record Date

 

Ex-Dividend Date

 

Payable Date

 

Cents-Per-Share

Ordinary Income

 

December 17, 2020

 

December 18, 2020

 

December 18, 2020

 

$0.02063

Total

 

 

 

 

 

 

 

$0.02063

Past performance is not a guarantee of future results.

Investing in the Funds involves risks including loss of principal. The Funds’ investment objectives, risks, charges, and expenses should be considered carefully before investing. The prospectus contains this and other important information about the Funds, and it may be obtained by calling Shareholder Services at (866) 202-2263 or visiting our website www.fairholmefunds.com. Read it carefully before investing.

The Fairholme Fund is non-diversified, which means that The Fairholme Fund invests in a smaller number of securities when compared to more diversified funds. Therefore, The Fairholme Fund is exposed to greater individual stock volatility than a diversified fund. The Fairholme Fund also invests in foreign securities which involve greater volatility and political, economic and currency risks and differences in accounting methods. The Fairholme Fund may also invest in “special situations” to achieve its objectives. These strategies may involve greater risks than other fund strategies.

The Fairholme Focused Income Fund (the “Income Fund”) is a non-diversified mutual fund, which means that the Income Fund invests in a smaller number of securities when compared to more diversified funds. This strategy exposes the Income Fund and its shareholders to greater risk of loss from adverse developments affecting portfolio companies. The Income Fund’s investments are also subject to interest rate risk, which is the risk that the value of a security will decline because of a change in general interest rates. Investments subject to interest rate risk will usually decrease in value when interest rates rise and rise in value when interest rates decline. Also, securities with long maturities typically experience a more pronounced change in value when interest rates change. Debt securities are subject to credit risk (potential default by the issuer). The Income Fund may invest without limit in lower-rated securities. Compared to higher-rated fixed income securities, lower-rated debt may entail greater risk of default and market volatility.

The Fairholme Allocation Fund (the “Allocation Fund”) is a non-diversified mutual fund, which means that the Allocation Fund can invest in a smaller number of securities when compared to more diversified funds. The Allocation Fund may invest in lower-rated securities, which may have greater market risk. This strategy exposes The Allocation Fund and its shareholders to greater risk of loss from adverse developments affecting portfolio companies. The allocation of investments among the different asset classes, such as equity or fixed-income asset classes, may have a more significant effect on The Allocation Fund’s net asset value when one of these classes is performing more poorly than others.

Fairholme Funds, Inc.

Jodi Lin, 305-358-3000

KEYWORDS: Florida United States North America

INDUSTRY KEYWORDS: Professional Services Finance

MEDIA:

Posted on

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Seneca Biopharma, Inc. Merger

WILMINGTON, Del., Dec. 18, 2020 (GLOBE NEWSWIRE) — Rigrodsky & Long, P.A. announces that it is investigating Seneca Biopharma, Inc. (“Seneca”) (NASDAQ CM: SNCA) regarding possible breaches of fiduciary duties and other violations of law related to Seneca’s agreement to merge with Leading BioSciences, Inc.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-seneca-biopharma-inc.

You may contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or [email protected].

Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising.  Prior results do not guarantee a similar outcome.

CONTACT:         

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free)
(302) 295-5310
Fax: (302) 654-7530
[email protected]
https://rl-legal.com



Posted on

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of GNB Financial Services, Inc. Merger

WILMINGTON, Del., Dec. 18, 2020 (GLOBE NEWSWIRE) — Rigrodsky & Long, P.A. announces that it is investigating GNB Financial Services, Inc. (“GNB Financial”) (OTC: GNBF) regarding possible breaches of fiduciary duties and other violations of law related to GNB Financial’s agreement to be acquired by LINKBANCORP, Inc. (“LINKBANCORP”) (OTC: LNKB). Under the terms of the agreement, GNB’s shareholders will receive either $87.68 in cash or 7.3064 shares of LINKBANCORP per share.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-gnb-financial-services-inc.

You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or [email protected].

Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising.  Prior results do not guarantee a similar outcome.

CONTACT:         

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free)
(302) 295-5310
Fax: (302) 654-7530
[email protected]
https://rl-legal.com



Posted on

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of New Providence Acquisition Corp. Merger

WILMINGTON, Del., Dec. 18, 2020 (GLOBE NEWSWIRE) — Rigrodsky & Long, P.A. announces that it is investigating New Providence Acquisition Corp. (“New Providence”) (NASDAQ CM: NPA) regarding possible breaches of fiduciary duties and other violations of law related to New Providence’s agreement to merge with AST & Science LLC.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-new-providence-acquisition-corp.

You may contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or [email protected].

Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising.  Prior results do not guarantee a similar outcome.

CONTACT:         

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free)
(302) 295-5310
Fax: (302) 654-7530
[email protected]
https://rl-legal.com



Posted on

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Tilray, Inc. Merger

WILMINGTON, Del., Dec. 18, 2020 (GLOBE NEWSWIRE) — Rigrodsky & Long, P.A. announces that it is investigating Tilray, Inc. (“Tilray”) (NASDAQ GS: TLRY) regarding possible breaches of fiduciary duties and other violations of law related to Tilray’s agreement to merge with Aphria Inc. (“Aphria”) (NASDAQ: APHA).  

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-tilray-inc.

You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or [email protected].

Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising.  Prior results do not guarantee a similar outcome.

CONTACT:         

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free)
(302) 295-5310
Fax: (302) 654-7530
[email protected]
https://rl-legal.com



Posted on

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Thunder Bridge Acquisition II, Ltd. Merger

WILMINGTON, Del., Dec. 18, 2020 (GLOBE NEWSWIRE) — Rigrodsky & Long, P.A. announces that it is investigating Thunder Bridge Acquisition II, Ltd. (“Thunder Bridge”) (NASDAQ GS: THBR) regarding possible breaches of fiduciary duties and other violations of law related to Thunder Bridge’s agreement to merge with indie Semiconductor.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-thunder-bridge-acquisition-ii-ltd.

You may contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or [email protected].

Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising.  Prior results do not guarantee a similar outcome.

CONTACT:         

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free)
(302) 295-5310
Fax: (302) 654-7530
[email protected]
https://rl-legal.com



Posted on

Guess & Co. Corporation Changes Principal Office

New Principal Office in Osage Beach, Missouri

OSAGE BEACH, Mo., Dec. 18, 2020 (GLOBE NEWSWIRE) — Guess & Co. Corporation is pleased to announce that it has moved its principal office from Miami, Florida to Osage Beach, Missouri as of December 14, 2020. Guess & Co. Corporation was incorporated in North Carolina in 2015 and began operations in August of 2017. In 2018, the company chose to be based in Miami, Florida. In conjunction with the company’s commitment to revitalizing Rural America, the company chose to move its headquarters to the Midwestern United States. The company secured office space in Osage Beach, Missouri and plans to begin hiring in the first quarter of 2021. “We are bullish on Rural America and while we will provide solutions throughout the nation, our focus is on revitalizing rural communities,” stated Jerry D. Guess, chairman and CEO.

As part of the move, Guess & Co. Corporation also re-aligned the core states of operation. The company is now operating in only four (4) states: Missouri, Kansas, Nebraska, North Carolina. The company has dedicated 60% of its business and plans to revitalize communities throughout Rural America. The Covid-19 pandemic has spurred interest in rural areas as many families move away from cities. Guess & Co. Corporation began exploring rural revitalization in 2018 and accelerated those plans amid the pandemic and is taking steps to implement its strategies in a prompt manner.


About Guess & Co. Corporation

Guess & Co. Corporation is an emerging stewardship solutions company with energy, health care, technology, and real estate units committed to revitalizing Rural America and select urban areas. We partner with communities, companies and governments to improve the welfare of people. Guess & Co. Corporation is a registered contractor with the U.S. Government to provide solutions to federal government agencies and members of our company have active top-secret/SCI clearances. We are based in Osage Beach, Missouri. Our company operates in Missouri, Kansas, Nebraska, and North Carolina. Guess & Co. Corporation was founded in August of 2017. The management team of Guess & Co. Corporation has over 50 years of combined experience.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3c1aac72-7a13-41ea-8f9b-6b57d51bc196



Media Contact:

Media Relations
[email protected]

Posted on

Shattuck Labs Added to Russell 2000® and 3000® Indexes

AUSTIN, TX and DURHAM, NC, Dec. 18, 2020 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced that it will be added to the Russell 2000® and 3000® Indexes effective December 21, 2020, following Russell’s quarterly additions of select initial public offerings.

“We are incredibly pleased to be included in the Russell 2000® and Russell 3000® Indexes,” said Andrew Neill, Shattuck’s Vice President of Finance and Corporate Strategy. “This milestone reflects the potential that investors see in Shattuck. Importantly, it increases our visibility in the investment community while broadening our institutional shareholder base.”

Russell indexes are part of FTSE Russell, a leading global index provider. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $9 trillion in assets are benchmarked against Russell’s US indexes.

About Shattuck Labs, Inc.

Shattuck is a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Compounds derived from Shattuck’s proprietary Agonist Redirected Checkpoint, ARC®, platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic. The company’s lead wholly owned program, SL-172154 (SIRPα-Fc-CD40L), which is designed to block the CD47 immune checkpoint and simultaneously agonize the CD40 pathway, is being evaluated in a Phase 1 trial. A second compound, SL-279252 (PD1-Fc-OX40L), is being evaluated in a Phase 1 trial in collaboration with Takeda Pharmaceuticals. Additionally, the company is advancing a proprietary Gamma Delta T Cell Engager, GADLEN™, platform, which is designed to bridge gamma delta T cells to tumor antigens for the treatment of patients with cancer. Shattuck has offices in both Austin, Texas and Durham, North Carolina. For more information, please visit: www.ShattuckLabs.com.

Investor Contact:

Conor Richardson
Senior Director, Finance & Investor Relations
Shattuck Labs, Inc.
[email protected]

Media Contact:

Stephanie Ascher
Managing Director
Stern Investor Relations, Inc.
[email protected]